NCT04839614
- Conditions
- Body Weight, EIN, Endometrial Cancer Stage I, +22 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Endometrial Cancer Stage I
Explore clinical trials studying Endometrial Cancer Stage I. Study availability and eligibility vary by location and protocol.
11 public trials
7 recruiting studies
Endometrial Cancer Stage I trial results
NCT04291612
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +22 more
- Locations
-
- Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
- Miami Cancer Institute Baptist Health South Florida Miami, Florida, United States
- ADVENTHEALTH (Data collection only) Orlando, Florida, United States
- Mayo Clinic (Data Collection and Data Analysis) Rochester, Minnesota, United States
Recruiting
Sentinel Node Biopsy in Endometrial Cancer
NCT04073706
- Conditions
- Endometrial Cancer Stage I, Endometrial Neoplasms, Female Urogenital Diseases, +12 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Hospital Britanico Buenos Aires, Ciudad Autónoma de Buenos Aires (caba), Argentina
- Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
- Liverpool Hospital Liverpool, New South Wales, Australia
NCT07040657
- Conditions
- Endometrial Cancer Stage I, Endometrial Neoplasms, Female Urogenital Diseases, +16 more
- Locations
-
- Ankara University Ankara, Turkey (Türkiye)
- Dokuz Eylul University Izmir, Turkey (Türkiye)
NCT05179447
- Conditions
- Endometrial Cancer Stage I, Endometrial Cancer Stage II, Endometrial Neoplasms, +11 more
- Locations
-
- Tongji Hospital, Huazhong University of Science and Technology Wuhan, Hubei, China
- Qilu Hospital of Shandong University Jinan, Shandong, China
- Women's Hospital School of Medicine Zhejiang University Hangzhou, Zhejiang, China
- Peking University Peoples Hospital Beijing, China
Recruiting
SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
NCT06278857
- Conditions
- Endometrial Cancer Stage I, Endometrial Neoplasms, Endometrioid Endometrial Adenocarcinoma, +14 more
- Locations
-
- Westmead Hospital Sydney, New South Wales, Australia
- Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
NCT06417736
- Conditions
- Endometrial Cancer Stage I, Endometrial Hyperplasia, Endometrial Neoplasms, +11 more
- Locations
-
- Women's Hospital School of Medicine Zhejiang University Hangzhou, Zhejiang, China
Not yet recruiting
SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer
NCT07462663
- Conditions
- Atypical Endometrial Hyperplasia, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I, BMI>40, +26 more
- Locations
-
Not specified
Active, not recruiting
PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer
NCT03469674
- Conditions
- Endometrial Cancer Stage I, Endometrial Cancer Stage II, Endometrial Neoplasms, +11 more
- Locations
-
- Medical University, Vienna Vienna, Austria
- University Hospital Gent Ghent, Belgium
- CEEGOG, General Faculty Hospital and First Faculty of Medicine, Charles University, Prague Prague, Czechia
- GINECO group - Institut Goustave Roussy Paris, France
NCT04972682
- Conditions
- Endometrial Adenocarcinoma, Endometrial Cancer, Endometrial Cancer Stage I, +17 more
- Locations
-
- 1. Department of Gynecologic Oncology, Moscow City Oncology Hospital No. 62 Istra, Moscow Oblast, Russia